Trial
NCT04852367
PanDox: Targeted Doxorubicin in Pancreatic Tumours
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Oxford
Collaborators
National Institute for Health Research, United Kingdom; Imunon
Condition
Pancreatic Ductal Adenocarcinoma
Intervention
Focused Ultrasound
Why stopped
Lack of recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-04-12